ADVM Market Cap History
Below is a table of the ADVM market cap history going back to 7/31/2014:

Date ADVM Market Cap

Also see: ADVM Shares Outstanding History
and ADVM YTD Return
ADVM Historical Market Cap:
-12.39% CAGR
ADVM Historical Market Cap: +-12.39% CAGR

Mouse over chart for data details
7/31/2014 ...10/29/2021
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. ADVM-022 is a single, in-office intravitreal injection gene therapy. ADVM-022 is being developed for the treatment of patients with chronic retinal diseases who respond to anti-vascular endothelial growth factor therapy, including wet age-related macular degeneration and diabetic macular edema. ADVM-022 utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette. We show 31 historical shares outstanding datapoints in our ADVM shares outstanding history coverage, used to compute ADVM market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADVM market cap history over the course of time is important for investors interested in comparing ADVM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADVM versus a peer is one thing; comparing ADVM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADVM can fluctuate over the course of history. With this page we aim to empower investors researching ADVM by allowing them to research the ADVM market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ADVM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adverum Biotechnologies (ADVM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ADXS Market Cap History
ADYX Market Cap History
AEMD Market Cap History
AERI Market Cap History
AEZS Market Cap History
AFIB Market Cap History
AGEN Market Cap History
AGIO Market Cap History
AGL Market Cap History
AGLE Market Cap History
More Healthcare companies »


ADVM Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.